Literature DB >> 20881940

Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells.

Zhengchao Wang1, Lin Tang, Qing Zhu, Fan Yi, Fan Zhang, Pin-Lan Li, Ningjun Li.   

Abstract

To examine whether hypoxia-inducible factor (HIF)-1α mediates the profibrotic effects of angiotensin II, we treated cultured renal medullary interstitial cells with angiotensin II and found that it increased HIF-1α levels. This was accompanied by a significant upregulation of collagen I/III, the tissue inhibitor of metalloproteinase-1, elevation of the proliferation marker proliferating cell nuclear antigen, and a transdifferentiation marker vimentin. All these effects of angiotensin II were completely blocked by siRNA for HIF-1α but not HIF-2α. Overexpression of a prolyl-hydroxylase domain-containing protein 2 (PHD2) transgene, the predominant renal HIF prolyl-hydroxylase, attenuated the effects of angiotensin II and its gene silencing enhanced the effects of angiotensin II. Removal of hydrogen peroxide eliminated angiotensin II-induced profibrotic effects. A 2-week infusion of rats with angiotensin II increased the expression of HIF-1α and α-smooth muscle actin, another marker of transdifferentiation, in renal medullary interstitial cells in vivo. Thus, our study suggests that HIF-1α mediates angiotensin II-induced profibrotic effects through activation of cell transdifferentiation. We propose that redox regulation of prolyl-PHD2 plays a critical role in angiotensin II-induced activation of HIF-1α in renal cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881940      PMCID: PMC3107572          DOI: 10.1038/ki.2010.326

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  86 in total

1.  Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.

Authors:  Ramesh Natarajan; Fadi N Salloum; Bernard J Fisher; Rakesh C Kukreja; Alpha A Fowler
Journal:  Circ Res       Date:  2005-11-23       Impact factor: 17.367

2.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

3.  Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species.

Authors:  Denis Feliers; Yves Gorin; Goutam Ghosh-Choudhury; Hanna E Abboud; Balakuntalam S Kasinath
Journal:  Am J Physiol Renal Physiol       Date:  2005-10-25

4.  Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells.

Authors:  Yong Luo; Da-lin He; Liang Ning; Shu-lin Shen; Lei Li; Xiang Li
Journal:  Chin Med J (Engl)       Date:  2006-05-05       Impact factor: 2.628

5.  Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1.

Authors:  Huasheng Lu; Clifton L Dalgard; Ahmed Mohyeldin; Thomas McFate; A Sasha Tait; Ajay Verma
Journal:  J Biol Chem       Date:  2005-10-13       Impact factor: 5.157

6.  Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.

Authors:  Jan H Marxsen; Petra Stengel; Kathrin Doege; Pekka Heikkinen; Terhi Jokilehto; Thomas Wagner; Wolfgang Jelkmann; Panu Jaakkola; Eric Metzen
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

Review 7.  Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy.

Authors:  Rajiv R Ratan; Ambreena Siddiq; Leila Aminova; Philipp S Lange; Brett Langley; Issam Ayoub; JoAnn Gensert; Juan Chavez
Journal:  Stroke       Date:  2004-10-07       Impact factor: 7.914

8.  Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling.

Authors:  Kebin Hu; Chuanyue Wu; Wendy M Mars; Youhua Liu
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 9.  The role of epithelial-to-mesenchymal transition in renal fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  J Mol Med (Berl)       Date:  2004-01-30       Impact factor: 4.599

Review 10.  Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics.

Authors:  Leon G Fine; Jill T Norman
Journal:  Kidney Int       Date:  2008-07-16       Impact factor: 10.612

View more
  47 in total

1.  Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.

Authors:  Yongzhen Zhao; Heng Zeng; Bo Liu; Xiaochen He; Jian-Xiong Chen
Journal:  Am J Physiol Renal Physiol       Date:  2020-07-27

2.  Diuretic, Natriuretic, and Vasodepressor Activity of a Lipid Fraction Enhanced in Medium of Cultured Mouse Medullary Interstitial Cells by a Selective Fatty Acid Amide Hydrolase Inhibitor.

Authors:  Zdravka Daneva; Sara K Dempsey; Ashfaq Ahmad; Ningjun Li; Pin-Lan Li; Joseph K Ritter
Journal:  J Pharmacol Exp Ther       Date:  2018-12-07       Impact factor: 4.030

Review 3.  Renal interstitial fibrosis: mechanisms and evaluation.

Authors:  Alton B Farris; Robert B Colvin
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

4.  Downregulation of microRNA-429 contributes to angiotensin II-induced profibrotic effect in rat kidney.

Authors:  Zhengchao Wang; Qing Zhu; Weili Wang; Junping Hu; Pin-Lan Li; Fan Yi; Ningjun Li
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-22

5.  Sphingosine kinase 1 inhibition decreases the epithelial-mesenchymal transition and ameliorates renal fibrosis via modulating NF-κB signaling.

Authors:  Fei He; Maoxiao Fan; Yansheng Jin; Haiyan Wang; Lan Ding; Jianfeng Fan; Shuaishuai Gu; Wen Xu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

6.  Angiotensin II: breathtaking in the renal medulla.

Authors:  Volker H Haase
Journal:  Kidney Int       Date:  2011-02       Impact factor: 10.612

7.  Klotho Ameliorates Medullary Fibrosis and Pressure Natriuresis in Hypertensive Rat Kidneys.

Authors:  Tsuneo Takenaka; Tsutomu Inoue; Takashi Miyazaki; Hiroyuki Kobori; Akira Nishiyama; Naohito Ishii; Matsuhiko Hayashi; Hiromichi Suzuki
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

8.  Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury.

Authors:  Caixia Li; Min Xia; Justine M Abais; Xiaocheng Liu; Ningjun Li; Krishna M Boini; Pin-Lan Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-27       Impact factor: 3.000

9.  DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys.

Authors:  Yu-Ting Chang; Ching-Chin Yang; Szu-Yu Pan; Yu-Hsiang Chou; Fan-Chi Chang; Chun-Fu Lai; Ming-Hsuan Tsai; Huan-Lun Hsu; Ching-Hung Lin; Wen-Chih Chiang; Ming-Shiou Wu; Tzong-Shinn Chu; Yung-Ming Chen; Shuei-Liong Lin
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

10.  Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3.

Authors:  Bethany Baumann; Tomoko Hayashida; Xiaoyan Liang; H William Schnaper
Journal:  Kidney Int       Date:  2016-08-05       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.